Publications by authors named "Linda D Bosserman"

Claim this Profile
T
Teams, Tools, Processes and Resources to Manage Oncologic Clinical Decision Support: Lessons Learned from City of Hope's Multistate, Academic, and Community Oncology Enterprise.
Linda D Bosserman, YiHsuan Lin, Sepideh Shayani, Brian Moore, Denise Morse

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UGT1A1*28 polymorphism and the risk of toxicity and disease progression in patients with breast cancer receiving sacituzumab govitecan.
Megan H Wong, Veronica C Jones, Wai Yu, Linda D Bosserman, Sayeh M Lavasani

Cancer Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans.
Linda D Bosserman, Isa Mambetsariev, Colton Ladbury, Afsaneh Barzi, Deron Johnson

J Clin Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in Cancer Care and Scientific Knowledge in Hispanic/Latinx People in the United States.
Linda D Bosserman, Narjust Duma, Miguel Villalona-Calero, Gilberto Lopes, Pelin Cinar

JCO Oncol Pract· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Comparison of Medical Oncologists and a Machine Learning Model to Predict 3-Month Mortality in Patients With Metastatic Solid Tumors.
Finly J Zachariah, Lorenzo A Rossi, Laura M Roberts, Linda D Bosserman

JAMA Netw Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing 's Cancer Care Delivery and Quality Improvement Mission With Equity and Value Components.
Linda D Bosserman

JCO Oncol Pract· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Landscape: Physician Compensation.
Christian A Thomas, Allison M Hirschorn, Julia E Tomkins, Walter E Birch, Linda D Bosserman

JCO Oncol Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience.
Linda D Bosserman, Mary Cianfrocca, Bertram Yuh, Christina Yeon, Helen Chen

J Clin Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to Improve Participation of Older Adults in Cancer Research.
Jennifer Liu, Eutiquio Gutierrez, Abhay Tiwari, Simran Padam, Daneng Li, Linda D Bosserman

J Clin Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Call to Action: Ethics Committee Roundtable Recommendations for Addressing Burnout and Moral Distress in Oncology.
Fay J Hlubocky, Lynne P Taylor, Jonathan M Marron, Rebecca A Spence, Molly M McGinnis, Linda D Bosserman

JCO Oncol Pract· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Kathy Pan, Linda Diana Bosserman, Rowan T Chlebowski

J Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits and Challenges of Growing Oncology Networks in the United States.
Linda D Bosserman

J Oncol Pract· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncology Clinical Pathways: Charting the Landscape of Pathway Providers.
Bobby Daly, Robin T Zon, Ray D Page, Stephen B Edge, Gary H Lyman, Linda D Bosserman

J Oncol Pract· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.
Catherine Van Poznak, Mark R Somerfield, William E Barlow, J Sybil Biermann, Linda D Bosserman

J Clin Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value-Based Medicine and Integration of Tumor Biology.
Gabriel A Brooks, Linda D Bosserman, Isa Mambetsariev, Ravi Salgia

Am Soc Clin Oncol Educ Book· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Denise A Yardley, Edward R Arrowsmith, Brooke R Daniel, Janice Eakle, Adam Brufsky, Linda D Bosserman

Breast Cancer Res Treat· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Clinical Oncology Criteria for High-Quality Clinical Pathways in Oncology.
Robin T Zon, Stephen B Edge, Ray D Page, James N Frame, Gary H Lyman, Linda D Bosserman

J Oncol Pract· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gary H Lyman, Mark R Somerfield, Linda D Bosserman, Cheryl L Perkins, Donald L Weaver

J Clin Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology.
Robin T Zon, James N Frame, Michael N Neuss, Ray D Page, Dana S Wollins, Linda D Bosserman

J Oncol Pract· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute.
Denise A Yardley, Linda D Bosserman, Joyce A O'Shaughnessy, William N Harwin, Susan K Morgan

Breast Cancer Res Treat· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to I.A. Voutsadakis et al and A. Goyal et al.
Armando E Giuliano, Linda D Bosserman, Stephen B Edge, Donald L Weaver, Gary H Lyman

J Clin Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenge of managing increasingly complex cancer toxicity.
Linda D Bosserman

Oncology (Williston Park)· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Linda D Bosserman

J Clin Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
Sara A Hurvitz, Linda D Bosserman, David Chan, Christopher T Hagenstad, Frederick C Kass

Springerplus· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary of oral abstract session B: innovating to improve care quality.
James A Hayman, Linda D Bosserman, Jason A Efstathiou

J Oncol Pract· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis